{
    "2018-04-23": [
        [
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：在整体市场调整中建议积极关注医药板块的优质公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "市场调整",
                        "优质公司"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药行业周报：市场波动首选医药 重点推荐乐普医疗、恒瑞医药等",
                "features": {
                    "keywords": [
                        "医药",
                        "市场波动",
                        "乐普医疗",
                        "恒瑞医药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[领先大市-A评级]医药行业每周观点：继续关注Q1业绩超预期和业绩落地支撑盈利向上 以及白马股调整带来投资机会",
                "features": {
                    "keywords": [
                        "医药",
                        "Q1业绩",
                        "白马股",
                        "投资机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业研究周报：板块估值持续消化 抓住成长股机遇",
                "features": {
                    "keywords": [
                        "医药生物",
                        "板块估值",
                        "成长股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}